GenapSys Gets Court OK For $42M Sale To Investor Group
Gene-sequencing company GenapSys Inc. won a bankruptcy court's approval Thursday to sell its assets to an investor group for $42 million despite a last-minute plea from Bolt Financial Inc.'s CEO Ryan...To view the full article, register now.
Already a subscriber? Click here to view full article